Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 42 of 42 entries
View as:

Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00554216 Org: User:
Start: 11/30/07 End: 05/31/09 Due: 05/31/10

Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00486291 Org: User:
Start: 06/30/07 End: 04/30/08 Due: 04/30/09

To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01054430 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

Study Evaluating the Effects of Avanafil on Semen Parameters

Phase: N/A Priority: Normal
NCT ID: NCT01768676 Org: User:
Start: 12/31/12 End: 08/31/14 Due: 08/31/15

A Thorough EKG Safety Study of TA-1790 (Avanafil)

Phase: N/A Priority: Normal
NCT ID: NCT00769041 Org: User:
Start: 10/31/08 End: 01/31/09 Due: 01/31/10

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00895011 Org: User:
Start: 04/30/09 End: 04/30/11 Due: 04/30/12

A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

Phase: N/A Priority: Normal
NCT ID: NCT00600067 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)

Phase: N/A Priority: Normal
NCT ID: NCT00809471 Org: User:
Start: 12/31/08 End: 02/28/10 Due: 02/28/11

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02714062 Org: User:
Start: 03/31/16 End: 11/30/16 Due: 11/30/17

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

Phase: N/A Priority: Normal
NCT ID: NCT01096329 Org: User:
Start: 02/28/10 End: - Due: -

VI-1121 for the Treatment Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01428362 Org: User:
Start: 08/31/11 End: 08/31/13 Due: 08/31/14

Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01415128 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

Topical Alprostadil for Female Sexual Arousal Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00324948 Org: User:
Start: 09/30/04 End: 11/30/06 Due: 11/30/07

Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00821496 Org: User:
Start: 01/31/09 End: 04/30/09 Due: 04/30/10

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06915246 Org: User:
Start: 03/12/25 End: 04/30/26 Due: 04/30/27

To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil

Phase: N/A Priority: Normal
NCT ID: NCT00770042 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00839891 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10